Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
149.1 USD | -1.43% | -1.18% | -22.31% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.31% | 19.13B | |
+31.28% | 50.85B | |
+1.24% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+10.98% | 26.11B | |
+7.56% | 13.05B | |
+26.80% | 12.16B | |
+23.00% | 12.08B | |
-5.99% | 11.58B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- BMO Capital Cuts Price Target on Alnylam Pharmaceuticals to $234 From $250, Maintains Outperform Rating